{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:51:19Z","timestamp":1785372679275,"version":"3.55.0"},"reference-count":191,"publisher":"Elsevier","isbn-type":[{"value":"9780443415333","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.acc.2024.11.005","type":"book-chapter","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T12:41:41Z","timestamp":1733834501000},"page":"55-91","source":"Crossref","is-referenced-by-count":3,"title":["Brain white matter damage biomarkers"],"prefix":"10.1016","author":[{"given":"Fardin","family":"Nabizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/bs.acc.2024.11.005_bib1","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tics.2009.04.008","article-title":"Corticocentric myopia: old bias in new cognitive sciences","volume":"13","author":"Parvizi","year":"2009","journal-title":"Trends Cogn. Sci."},{"issue":"20","key":"10.1016\/bs.acc.2024.11.005_bib2","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1093\/cercor\/bhab500","article-title":"A taxonomy of the brain\u2019s white matter: twenty-one major tracts for the 21st century","volume":"32","author":"Bullock","year":"2022","journal-title":"Cereb. Cortex"},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","article-title":"White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes","volume":"6","author":"Nasrabady","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib4","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1007\/s00429-015-1097-5","article-title":"Brain white matter structure and information processing speed in healthy older age","volume":"221","author":"Kuznetsova","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/bs.acc.2024.11.005_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tine.2019.02.004","article-title":"Whole-brain white matter organization, intelligence, and educational attainment","volume":"15","author":"Bathelt","year":"2019","journal-title":"Trends Neurosci. Educ."},{"key":"10.1016\/bs.acc.2024.11.005_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.dcn.2022.101173","article-title":"Deviations from normative brain white and gray matter structure are associated with psychopathology in youth","volume":"58","author":"Kjelkenes","year":"2022","journal-title":"Dev. Cogn. Neurosci."},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2020.101111","article-title":"Neonatal white matter damage and the fetal inflammatory response","volume":"25","author":"Gilles","year":"2020","journal-title":"Semin. Fetal Neonatal Med."},{"issue":"8","key":"10.1016\/bs.acc.2024.11.005_bib8","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1177\/0271678X21990980","article-title":"White matter network damage mediates association between cerebrovascular disease and cognition","volume":"41","author":"Hilal","year":"2021","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mds.28864","article-title":"Longitudinal white matter damage evolution in Parkinson\u2019s disease","volume":"37","author":"Scamarcia","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.acc.2024.11.005_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropsychologia.2021.107980","article-title":"Geometric microstructural damage of white matter with functional compensation in post-stroke","volume":"160","author":"Zhao","year":"2021","journal-title":"Neuropsychologia"},{"issue":"5","key":"10.1016\/bs.acc.2024.11.005_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/1573405614666180801112844","article-title":"Novel automated method for the detection of white matter hyperintensities in brain multispectral MR images","volume":"16","author":"Chen","year":"2020","journal-title":"Curr. Med. Imaging"},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jmri.28797","article-title":"Associations of MRI-derived glymphatic system impairment with global white matter damage and cognitive impairment in mild traumatic brain injury: a DTI-ALPS study","volume":"59","author":"Yang","year":"2024","journal-title":"J. Magn. Reson. Imaging"},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib13","doi-asserted-by":"crossref","first-page":"2450001","DOI":"10.1142\/S0129065724500011","article-title":"Neonatal white matter damage analysis using DTI super-resolution and multi-modality image registration","volume":"34","author":"Wang","year":"2024","journal-title":"Int. J. Neural Syst."},{"issue":"10","key":"10.1016\/bs.acc.2024.11.005_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneurol.2016.127","article-title":"Fluid biomarkers for mild traumatic brain injury and related conditions","volume":"12","author":"Zetterberg","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/B:NEUR.0000044195.64009.27","article-title":"A fourth type of neuroglial cell in the adult central nervous system","volume":"33","author":"Peters","year":"2004","journal-title":"J. Neurocytol."},{"issue":"7","key":"10.1016\/bs.acc.2024.11.005_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tins.2008.04.001","article-title":"White matter in learning, cognition and psychiatric disorders","volume":"31","author":"Fields","year":"2008","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/nbm.683","article-title":"Magnetization transfer in MRI: a review","volume":"14","author":"Henkelman","year":"2001","journal-title":"NMR Biomed."},{"key":"10.1016\/bs.acc.2024.11.005_bib19","doi-asserted-by":"crossref","first-page":"58s","DOI":"10.1177\/1051228405282242","article-title":"Magnetization transfer imaging in multiple sclerosis","volume":"15","author":"Horsfield","year":"2005","journal-title":"J. Neuroimaging"},{"key":"10.1016\/bs.acc.2024.11.005_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuroimage.2012.06.081","article-title":"White matter integrity, fiber count, and other fallacies: the do\u2019s and don\u2019ts of diffusion MRI","volume":"73","author":"Jones","year":"2013","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/mrm.1910310614","article-title":"In vivo visualization of myelin water in brain by magnetic resonance","volume":"31","author":"MacKay","year":"1994","journal-title":"Magn. Reson. Med."},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/1352458506070928","article-title":"Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology","volume":"12","author":"Laule","year":"2006","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib23","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jmri.25693","article-title":"Clinical quantitative susceptibility mapping (QSM): biometal imaging and its emerging roles in patient care","volume":"46","author":"Wang","year":"2017","journal-title":"J. Magn. Reson. Imaging"},{"issue":"10","key":"10.1016\/bs.acc.2024.11.005_bib24","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/nbm.3383","article-title":"Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range","volume":"28","author":"Wei","year":"2015","journal-title":"NMR Biomed."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.zemedi.2018.11.002","article-title":"An overview of deep learning in medical imaging focusing on MRI","volume":"29","author":"Lundervold","year":"2019","journal-title":"Z. f\u00fcr Medizinische Phys."},{"key":"10.1016\/bs.acc.2024.11.005_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2021.100723","article-title":"An overview of deep learning in medical imaging","volume":"26","author":"Anaya-Isaza","year":"2021","journal-title":"Inform. Med. Unlocked"},{"issue":"5","key":"10.1016\/bs.acc.2024.11.005_bib27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1089\/neu.2019.6890","article-title":"Damage mechanisms to oligodendrocytes and white matter in central nervous system injury: the australian context","volume":"37","author":"Warnock","year":"2020","journal-title":"J. Neurotrauma"},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000090293","article-title":"Pathophysiology of brain ischemia: penumbra, gene expression, and future therapeutic options","volume":"54","author":"Schaller","year":"2005","journal-title":"Eur. Neurol."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib29","doi-asserted-by":"crossref","first-page":"a020479","DOI":"10.1101\/cshperspect.a020479","article-title":"Oligodendrocytes: myelination and axonal support","volume":"8","author":"Simons","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"7","key":"10.1016\/bs.acc.2024.11.005_bib30","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/01.STR.26.7.1293","article-title":"The significance of cerebral white matter abnormalities 100 years after Binswanger\u2019s report. A review","volume":"26","author":"Pantoni","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/bs.acc.2024.11.005_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fneur.2019.00072","article-title":"Predicting motor outcomes in stroke patients using diffusion spectrum MRI microstructural measures","volume":"10","author":"Hodgson","year":"2019","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/aps.2014.1","article-title":"Glutamate transporters in brain ischemia: to modulate or not?","volume":"35","author":"Krzy\u017canowska","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/bs.acc.2024.11.005_bib33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.STR.0000256294.46009.29","article-title":"Ca2+ signals and neuronal death in brain ischemia","volume":"38","author":"Bano","year":"2007","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/bs.acc.2024.11.005_bib34","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s10495-010-0481-0","article-title":"Molecular and cellular mechanisms of excitotoxic neuronal death","volume":"15","author":"Wang","year":"2010","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/glia.20610","article-title":"Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury","volume":"56","author":"Lai","year":"2008","journal-title":"Glia"},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib36","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jpeds.2013.02.003","article-title":"Long-term neurodevelopmental outcome with hypoxic-ischemic encephalopathy","volume":"163","author":"Perez","year":"2013","journal-title":"J. Pediatr."},{"issue":"10","key":"10.1016\/bs.acc.2024.11.005_bib37","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2174\/0929867322666150209154036","article-title":"Inflammatory responses in brain ischemia","volume":"22","author":"Kawabori","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/1073858419848293","article-title":"Brain injury-mediated neuroinflammatory response and Alzheimer\u2019s disease","volume":"26","author":"Kempuraj","year":"2020","journal-title":"Neuroscientist"},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12975-011-0072-6","article-title":"Minocycline development for acute ischemic stroke","volume":"2","author":"Fagan","year":"2011","journal-title":"Transl. Stroke Res."},{"issue":"10","key":"10.1016\/bs.acc.2024.11.005_bib40","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","article-title":"Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: an mechanistic approach","volume":"18","author":"Singh","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/bs.acc.2024.11.005_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.expneurol.2014.04.026","article-title":"N-acetylcysteine amide preserves mitochondrial bioenergetics and improves functional recovery following spinal trauma","volume":"257","author":"Patel","year":"2014","journal-title":"Exp. Neurol."},{"issue":"11","key":"10.1016\/bs.acc.2024.11.005_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116224","article-title":"Neuroinflammation in vascular cognitive impairment and dementia: current evidence, advances, and prospects","volume":"23","author":"Tian","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 3","key":"10.1016\/bs.acc.2024.11.005_bib43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/brain\/awg061","article-title":"Axonal damage: a key predictor of outcome in human CNS diseases","volume":"126","author":"Medana","year":"2003","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12031-007-0029-0","article-title":"Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review","volume":"34","author":"Assaf","year":"2008","journal-title":"J. Mol. Neurosci."},{"issue":"11","key":"10.1016\/bs.acc.2024.11.005_bib45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrn1788","article-title":"Axon degeneration mechanisms: commonality amid diversity","volume":"6","author":"Coleman","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/bs.acc.2024.11.005_bib46","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/WNL.54.5.1155","article-title":"A Wallerian degeneration pattern in patients at risk for MS","volume":"54","author":"Simon","year":"2000","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.acc.2024.11.005_bib47","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S1474-4422(19)30078-X","article-title":"Global brain inflammation in stroke","volume":"18","author":"Shi","year":"2019","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib48","doi-asserted-by":"crossref","first-page":"C343","DOI":"10.1152\/ajpcell.00095.2018","article-title":"Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection","volume":"315","author":"Abdullahi","year":"2018","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5","key":"10.1016\/bs.acc.2024.11.005_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","article-title":"Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.acc.2024.11.005_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.595962","article-title":"Relationship between type 2 diabetes and white matter hyperintensity: a systematic review","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00125-007-0904-9","article-title":"The effects of type 1 diabetes on cerebral white matter","volume":"51","author":"Weinger","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/bs.acc.2024.11.005_bib52","article-title":"Antioxidant and neuroprotective actions of resveratrol in cerebrovascular diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12975-022-01119-z","article-title":"Resveratrol preconditioning downregulates PARP1 protein to alleviate PARP1-mediated cell death following cerebral ischemia","volume":"15","author":"Jackson","year":"2024","journal-title":"Transl. Stroke Res."},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib54","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1046\/j.1471-4159.2000.0751716.x","article-title":"Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia","volume":"75","author":"Nagayama","year":"2000","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/bs.acc.2024.11.005_bib55","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3390\/jcm11071864","article-title":"The assessment of endovascular therapies in ischemic stroke: management, problems and future approaches","volume":"11","author":"Popiela","year":"2022","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s13346-011-0046-y","article-title":"Advances in stroke therapy","volume":"1","author":"Jaffer","year":"2011","journal-title":"Drug. Deliv. Transl. Res."},{"key":"10.1016\/bs.acc.2024.11.005_bib57","first-page":"9168731","article-title":"Update in the early management and reperfusion strategies of patients with acute ischemic stroke","volume":"2018","author":"Mendez","year":"2018","journal-title":"Crit. Care Res. Pract."},{"issue":"43","key":"10.1016\/bs.acc.2024.11.005_bib58","doi-asserted-by":"crossref","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","article-title":"Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord","volume":"29","author":"Kigerl","year":"2009","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/bs.acc.2024.11.005_bib59","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/STROKEAHA.110.593129","article-title":"Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia","volume":"42","author":"Zhang","year":"2011","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/bs.acc.2024.11.005_bib60","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"6301","key":"10.1016\/bs.acc.2024.11.005_bib61","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"10.1016\/bs.acc.2024.11.005_bib62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuroscience.2015.06.038","article-title":"TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects","volume":"302","author":"Probert","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/bs.acc.2024.11.005_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102303","article-title":"Systemic inflammation after spinal cord injury: a review of biological evidence, related health risks, and potential therapies","volume":"67","author":"Bigford","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"issue":"10","key":"10.1016\/bs.acc.2024.11.005_bib64","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/35094583","article-title":"Cytokines and acute neurodegeneration","volume":"2","author":"Allan","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/bs.acc.2024.11.005_bib65","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib66","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1586\/14737175.4.4.571","article-title":"Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS","volume":"4","author":"Rudick","year":"2004","journal-title":"Expert. Rev. Neurother."},{"issue":"0 2","key":"10.1016\/bs.acc.2024.11.005_bib67","doi-asserted-by":"crossref","first-page":"ii111","DOI":"10.1136\/annrheumdis-2012-202576","article-title":"Janus kinase inhibitors in autoimmune diseases","volume":"72","author":"O\u2019Shea","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/imr.12169","article-title":"Regulatory T cells in autoimmune neuroinflammation","volume":"259","author":"Kleinewietfeld","year":"2014","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/bs.acc.2024.11.005_bib69","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2024.11.005_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/946048","article-title":"Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions","volume":"2012","author":"Ogata","year":"2012","journal-title":"Int. J. Rheumatol."},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib71","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1469-7580.2007.00733.x","article-title":"Excitotoxic damage to white matter","volume":"210","author":"Matute","year":"2007","journal-title":"J. Anat."},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib72","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.WCB.0000053472.41007.F9","article-title":"Oligodendrocytes and ischemic brain injury","volume":"23","author":"Dewar","year":"2003","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib73","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1191\/1352458503ms965oa","article-title":"Blood-brain barrier disruption in multiple sclerosis","volume":"9","author":"Minagar","year":"2003","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib74","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"issue":"Pt 7","key":"10.1016\/bs.acc.2024.11.005_bib75","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/brain\/awr014","article-title":"Enhancing remyelination in disease\u2014Can we wrap it up?","volume":"134","author":"Kotter","year":"2011","journal-title":"Brain"},{"issue":"10","key":"10.1016\/bs.acc.2024.11.005_bib76","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrn2229","article-title":"Pathologically activated therapeutics for neuroprotection","volume":"8","author":"Lipton","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/bs.acc.2024.11.005_bib77","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/14656566.2017.1319937","article-title":"Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis","volume":"18","author":"Sawada","year":"2017","journal-title":"Expert. Opin. Pharmacother."},{"issue":"10","key":"10.1016\/bs.acc.2024.11.005_bib78","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/npp.2009.64","article-title":"Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation","volume":"34","author":"Wu","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"6 4","key":"10.1016\/bs.acc.2024.11.005_bib79","first-page":"S233","article-title":"The pharmacology and mechanism of action of riluzole","volume":"47","author":"Doble","year":"1996","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.acc.2024.11.005_bib80","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","article-title":"Remyelination in the CNS: from biology to therapy","volume":"9","author":"Franklin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/bs.acc.2024.11.005_bib81","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrd.2017.115","article-title":"Remyelination therapies: a new direction and challenge in multiple sclerosis","volume":"16","author":"Plemel","year":"2017","journal-title":"Nat. Rev. Drug. Discovery"},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib82","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/glia.22755","article-title":"Zebrafish as a model to investigate CNS myelination","volume":"63","author":"Preston","year":"2015","journal-title":"Glia"},{"issue":"4-5","key":"10.1016\/bs.acc.2024.11.005_bib83","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1242\/dmm.001248","article-title":"Zebrafish myelination: a transparent model for remyelination?","volume":"1","author":"Buckley","year":"2008","journal-title":"Dis. Model. Mech."},{"issue":"9","key":"10.1016\/bs.acc.2024.11.005_bib84","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1474-4422(19)30137-1","article-title":"Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial","volume":"18","author":"Cadavid","year":"2019","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/bs.acc.2024.11.005_bib85","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jalz.2014.08.099","article-title":"Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer\u2019s disease research","volume":"11","author":"O\u2019Bryant","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/bs.acc.2024.11.005_bib86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2020.07.018","article-title":"Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer\u2019s disease","volume":"95","author":"Andersson","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib87","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00726-021-03111-7","article-title":"Multiple sclerosis and myelin basic protein: insights into protein disorder and disease","volume":"54","author":"Martinsen","year":"2022","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.21638\/spbu03.2022.206","article-title":"Role of the MBP protein in myelin formation and degradation in the brain","volume":"67","author":"Shenfeld","year":"2022","journal-title":"Biol. Commun."},{"issue":"8","key":"10.1016\/bs.acc.2024.11.005_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070019","article-title":"Biomarker report from the phase II lamotrigine trial in secondary progressive MS \u2013 neurofilament as a surrogate of disease progression","volume":"8","author":"Gnanapavan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2024.11.005_bib90","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.2147\/NDT.S125620","article-title":"Biomarkers in traumatic brain injury (TBI): a review","volume":"14","author":"Dadas","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib91","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/dneu.22552","article-title":"Advances in noninvasive myelin imaging","volume":"78","author":"Heath","year":"2018","journal-title":"Dev. Neurobiol."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib92","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40035-022-00321-1","article-title":"Myelin repair in Alzheimer\u2019s disease: a review of biological pathways and potential therapeutics","volume":"11","author":"Hirschfeld","year":"2022","journal-title":"Transl. Neurodegeneration"},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib93","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrneurol.2013.9","article-title":"Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood","volume":"9","author":"Zetterberg","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/bs.acc.2024.11.005_bib94","doi-asserted-by":"crossref","first-page":"1079757","DOI":"10.3389\/fneur.2023.1079757","article-title":"Advances in biotechnology and clinical therapy in the field of peripheral nerve regeneration based on magnetism","volume":"14","author":"Fan","year":"2023","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib95","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/135245859800400105","article-title":"Myelin basic protein in cerebrospinal fluid and other body fluids","volume":"4","author":"Whitaker","year":"1998","journal-title":"Multiple Scler. J."},{"issue":"22","key":"10.1016\/bs.acc.2024.11.005_bib96","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib97","doi-asserted-by":"crossref","first-page":"fcae132","DOI":"10.1093\/braincomms\/fcae132","article-title":"CSF neurofilament light chain profiling and quantitation in neurological diseases","volume":"6","author":"Leckey","year":"2024","journal-title":"Brain Commun."},{"issue":"8","key":"10.1016\/bs.acc.2024.11.005_bib98","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/1352458517715132","article-title":"Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod","volume":"24","author":"Piehl","year":"2018","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/bs.acc.2024.11.005_bib99","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s40520-022-02095-y","article-title":"Plasma neurofilament light levels correlate with white matter damage prior to Alzheimer\u2019s disease: results from ADNI","volume":"34","author":"Nabizadeh","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib100","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum Neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib101","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/bs.acc.2024.11.005_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105072","article-title":"Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barr\u00e9 syndrome","volume":"102","author":"van Tilburg","year":"2024","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/bs.acc.2024.11.005_bib103","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/bs.acc.2024.11.005_bib104","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/bs.acc.2024.11.005_bib105","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib106","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1586\/14737159.8.4.479","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases","volume":"8","author":"Tumani","year":"2008","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib107","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-0270(94)90011-6","article-title":"A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults","volume":"51","author":"Rosengren","year":"1994","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76990-7","article-title":"Renal function is associated with blood neurofilament light chain level in older adults","volume":"10","author":"Akamine","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib109","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13195-022-01134-0","article-title":"Association of neurofilament light chain with renal function: mechanisms and clinical implications","volume":"14","author":"Tang","year":"2022","journal-title":"Alzheimers Res. Ther."},{"issue":"5","key":"10.1016\/bs.acc.2024.11.005_bib110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders\u2014towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib111","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jamaneurol.2018.3746","article-title":"Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders","volume":"76","author":"Olsson","year":"2019","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib112","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","article-title":"Core candidate neurochemical and imaging biomarkers of Alzheimer\u2019s disease","volume":"4","author":"Hampel","year":"2008","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib113","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s11011-022-00908-7","article-title":"Plasma phosphorylated-tau181 levels reflect white matter microstructural changes across Alzheimer\u2019s disease progression","volume":"37","author":"Nabizadeh","year":"2022","journal-title":"Metab. Brain Dis."},{"issue":"8","key":"10.1016\/bs.acc.2024.11.005_bib114","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/brain\/awz162","article-title":"White matter hyperintensities: relationship to amyloid and tau burden","volume":"142","author":"Graff-Radford","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrd2176","article-title":"Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics","volume":"6","author":"Shaw","year":"2007","journal-title":"Nat. Rev. Drug. Discovery"},{"issue":"9","key":"10.1016\/bs.acc.2024.11.005_bib116","doi-asserted-by":"crossref","first-page":"a006221","DOI":"10.1101\/cshperspect.a006221","article-title":"Fluid biomarkers in Alzheimer disease","volume":"2","author":"Blennow","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib117","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3233\/JAD-130203","article-title":"The AD-CSF-index discriminates Alzheimer\u2019s disease patients from healthy controls: a validation study","volume":"36","author":"Molinuevo","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib118","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib119","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"Jama"},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib121","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jalz.2015.08.003","article-title":"Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study","volume":"12","author":"Duits","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"Pt 9","key":"10.1016\/bs.acc.2024.11.005_bib122","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/brain\/awv181","article-title":"Cerebrospinal fluid tau and amyloid-\u03b21-42 in patients with dementia","volume":"138","author":"Skillb\u00e4ck","year":"2015","journal-title":"Brain"},{"issue":"7","key":"10.1016\/bs.acc.2024.11.005_bib123","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.acc.2024.11.005_bib124","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2014.12.027","article-title":"Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease","volume":"1600","author":"Petzold","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/bs.acc.2024.11.005_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108624","article-title":"Serum glial fibrillary acidic protein is a body fluid biomarker: a valuable prognostic for neurological disease \u2013 a systematic review","volume":"107","author":"Heimfarth","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/bs.acc.2024.11.005_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.835597","article-title":"GFAP and S100B: What you always wanted to know and never dared to ask","volume":"13","author":"Janigro","year":"2022","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib127","doi-asserted-by":"crossref","first-page":"10381","DOI":"10.1038\/s41598-020-67504-6","article-title":"Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis","volume":"10","author":"Thebault","year":"2020","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/bs.acc.2024.11.005_bib128","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib129","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.2005.074823","article-title":"Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke","volume":"77","author":"Foerch","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib131","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci."},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib132","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbamcr.2008.11.009","article-title":"S100B\u2019s double life: intracellular regulator and extracellular signal","volume":"1793","author":"Donato","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056805","article-title":"Consequences of repeated blood-brain barrier disruption in football players","volume":"8","author":"Marchi","year":"2013","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/bs.acc.2024.11.005_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152274","article-title":"Multifunctional role of S100 protein family in the immune system: an update","volume":"11","author":"Singh","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib135","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10143-021-01678-z","article-title":"S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy","volume":"45","author":"Amoo","year":"2022","journal-title":"Neurosurg. Rev."},{"issue":"9","key":"10.1016\/bs.acc.2024.11.005_bib136","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/01.STR.0000138730.03264.ac","article-title":"Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion","volume":"35","author":"Foerch","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib137","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12868-023-00807-2","article-title":"Mini review: current status and perspective of S100B protein as a biomarker in daily clinical practice for diagnosis and prognosticating of clinical outcome in patients with neurological diseases with focus on acute brain injury","volume":"24","author":"Abboud","year":"2023","journal-title":"BMC Neurosci."},{"issue":"Pt 1","key":"10.1016\/bs.acc.2024.11.005_bib138","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/000456320003700101","article-title":"Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance","volume":"37","author":"Finney","year":"2000","journal-title":"Ann. Clin. Biochem."},{"issue":"12","key":"10.1016\/bs.acc.2024.11.005_bib139","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/ng.2007.29","article-title":"Cystatin C inhibits amyloid-beta deposition in Alzheimer\u2019s disease mouse models","volume":"39","author":"Mi","year":"2007","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/bs.acc.2024.11.005_bib140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1212\/WNL.0b013e318247caa1","article-title":"Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease","volume":"78","author":"Watabe-Rudolph","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib141","doi-asserted-by":"crossref","first-page":"349","DOI":"10.31083\/j.jin2002034","article-title":"On the correlation between serum Cystatin C and Parkinson\u2019s disease in the Chinese population: a promising biomarker?","volume":"20","author":"Yang","year":"2021","journal-title":"J. Integr. Neurosci."},{"issue":"14","key":"10.1016\/bs.acc.2024.11.005_bib142","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1212\/01.wnl.0000326894.40353.93","article-title":"Serum cystatin C and the risk of Alzheimer disease in elderly men","volume":"71","author":"Sundel\u00f6f","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/bs.acc.2024.11.005_bib143","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-2423(01)35015-1","article-title":"Cystatin C\u2014properties and use as diagnostic marker","volume":"35","author":"Grubb","year":"2000","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/bs.acc.2024.11.005_bib144","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0083-6729(00)58022-4","article-title":"Prostaglandin D synthase: structure and function","volume":"58","author":"Urade","year":"2000","journal-title":"Vitam. Horm."},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1471-4159.2004.02870.x","article-title":"Prostaglandin D2 mediates neuronal protection via the DP1 receptor","volume":"92","author":"Liang","year":"2005","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib146","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2990.2005.00690.x","article-title":"Lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive oligodendrocytes and astrocytes in the chronic multiple sclerosis","volume":"32","author":"Kagitani-Shimono","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib147","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/1096-9861(20001204)428:1<62::AID-CNE6>3.0.CO;2-E","article-title":"Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat","volume":"428","author":"Beuckmann","year":"2000","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib148","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1042\/BJ20111889","article-title":"Lipocalin-type prostaglandin D synthase protects against oxidative stress-induced neuronal cell death","volume":"443","author":"Fukuhara","year":"2012","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib149","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1750-3639.2008.00195.x","article-title":"Brain extracellular matrix in neurodegeneration","volume":"19","author":"Bonneh-Barkay","year":"2009","journal-title":"Brain Pathol."},{"issue":"Pt 4","key":"10.1016\/bs.acc.2024.11.005_bib150","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","article-title":"Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis","volume":"133","author":"Comabella","year":"2010","journal-title":"Brain"},{"issue":"10","key":"10.1016\/bs.acc.2024.11.005_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13101364","article-title":"Peripheral blood and cerebrospinal fluid levels of YKL-40 in Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2023","journal-title":"Brain Sci."},{"issue":"4","key":"10.1016\/bs.acc.2024.11.005_bib152","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208075","article-title":"Association of plasma YKL-40 with MRI, CSF, and cognitive markers of brain health and dementia","volume":"102","author":"Pase","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/bs.acc.2024.11.005_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148318","article-title":"YKL-40 as a novel biomarker related to white matter damage and cognitive impairment in patients with cerebral small vessel disease","volume":"1807","author":"Zhang","year":"2023","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib154","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrneurol.2016.68","article-title":"Extracellular vesicles in neurodegenerative disease \u2013 pathogenesis to biomarkers","volume":"12","author":"Thompson","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib155","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib156","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jnnp.56.1.32","article-title":"The significance of serum oligoclonal bands in neurological diseases","volume":"56","author":"Zeman","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/bs.acc.2024.11.005_bib157","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1177\/1352458513482374","article-title":"A comparative study of CSF neurofilament light and heavy chain protein in MS","volume":"19","author":"Kuhle","year":"2013","journal-title":"Mult. Scler."},{"issue":"13 Pt 2","key":"10.1016\/bs.acc.2024.11.005_bib158","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.wnl.0000280576.73609.c6","article-title":"Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?","volume":"70","author":"Tintor\u00e9","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/bs.acc.2024.11.005_bib159","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.msard.2019.03.027","article-title":"CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS","volume":"31","author":"Pardini","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0166-2236(96)10072-2","article-title":"GAP-43: an intrinsic determinant of neuronal development and plasticity","volume":"20","author":"Benowitz","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/bs.acc.2024.11.005_bib161","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fncel.2017.00266","article-title":"A shift from a pivotal to supporting role for the growth-associated protein (GAP-43) in the coordination of axonal structural and functional plasticity","volume":"11","author":"Holahan","year":"2017","journal-title":"Front. Cell Neurosci."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib162","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3171\/jns.1994.80.2.0301","article-title":"A new model of diffuse brain injury in rats. Part II: morphological characterization","volume":"80","author":"Foda","year":"1994","journal-title":"J. Neurosurg."},{"issue":"25","key":"10.1016\/bs.acc.2024.11.005_bib163","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.1523\/JNEUROSCI.0414-09.2009","article-title":"Inosine alters gene expression and axonal projections in neurons contralateral to a cortical infarct and improves skilled use of the impaired limb","volume":"29","author":"Zai","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.acc.2024.11.005_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.61186\/nl.3.2.1","article-title":"Level of CSF GAP-43 and white matter microstructural changes in Alzheimer\u2019s disease","volume":"3","author":"Assefi","year":"2024","journal-title":"Neurol. Lett."},{"key":"10.1016\/bs.acc.2024.11.005_bib165","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/978-3-319-57193-5_20","article-title":"Biomarkers in neurodegenerative diseases","volume":"15","author":"Jeromin","year":"2017","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/bs.acc.2024.11.005_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2023.100062","article-title":"Fluid biomarkers for the diagnosis of neurodegenerative diseases","volume":"8","author":"Luebke","year":"2023","journal-title":"Biomarkers Neuropsychiatry"},{"issue":"11","key":"10.1016\/bs.acc.2024.11.005_bib167","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/WNL.0000000000003085","article-title":"Neurofilament light chain level is a weak risk factor for the development of MS","volume":"87","author":"Arrambide","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/bs.acc.2024.11.005_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140311","article-title":"Longitudinal assessment of tau pathology in patients with Alzheimer\u2019s disease using [18F]THK-5117 positron emission tomography","volume":"10","author":"Ishiki","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib169","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13195-020-00612-7","article-title":"Imaging biomarkers in neurodegeneration: current and future practices","volume":"12","author":"Young","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib170","doi-asserted-by":"crossref","first-page":"20s","DOI":"10.2967\/jnumed.121.263196","article-title":"Tau PET imaging in neurodegenerative disorders","volume":"63","author":"Groot","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib171","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1212\/WNL.0000000000207389","article-title":"Longitudinal associations between blood biomarkers and white matter MRI in sport-related concussion: a study of the NCAA-DoD CARE consortium","volume":"101","author":"Wu","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib172","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-220846","article-title":"Regional white matter hyperintensities and Alzheimer\u2019s disease biomarkers among older adults with normal cognition and mild cognitive impairment","volume":"92","author":"Newton","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/bs.acc.2024.11.005_bib173","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s13054-015-1081-8","article-title":"Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study","volume":"19","author":"Lei","year":"2015","journal-title":"Crit. Care"},{"key":"10.1016\/bs.acc.2024.11.005_bib174","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/JIR.S398701","article-title":"Serum YKL-40 levels and white matter hyperintensities in patients with acute ischemic stroke","volume":"16","author":"Shi","year":"2023","journal-title":"J. Inflamm. Res."},{"issue":"3","key":"10.1016\/bs.acc.2024.11.005_bib175","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jnc.14894","article-title":"Cystatin C improves blood-brain barrier integrity after ischemic brain injury in mice","volume":"153","author":"Yang","year":"2020","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/bs.acc.2024.11.005_bib176","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1074\/jbc.M111.330662","article-title":"Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib177","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93498-w","article-title":"New candidate blood biomarkers potentially associated with white matter hyperintensities progression","volume":"11","author":"Jim\u00e9nez-Balado","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2024.11.005_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1065904","article-title":"The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer\u2019s disease","volume":"14","author":"Clark","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100557","article-title":"Ultrasensitive protein detection technologies for extracellular vesicle measurements","volume":"22","author":"Shami-Shah","year":"2023","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/bs.acc.2024.11.005_bib180","first-page":"1308","article-title":"Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis","volume":"20","author":"Kouchaki","year":"2021","journal-title":"Excli J."},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib181","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s12551-021-00849-y","article-title":"Human disease biomarker panels through systems biology","volume":"13","author":"Smith","year":"2021","journal-title":"Biophys. Rev."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib182","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-023-01168-y","article-title":"Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit","volume":"15","author":"Johnson","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/bs.acc.2024.11.005_bib183","series-title":"Fundamentals of Clinical Data Science. Cham (CH)","first-page":"153","article-title":"Clinical decision support systems","author":"Wasylewicz","year":"2019"},{"issue":"5","key":"10.1016\/bs.acc.2024.11.005_bib184","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052761","article-title":"Machine learning and novel biomarkers for the diagnosis of Alzheimer\u2019s disease","volume":"22","author":"Chang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/bs.acc.2024.11.005_bib185","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/brain\/awaa155","article-title":"Longitudinal neuroimaging biomarkers differ across Alzheimer\u2019s disease phenotypes","volume":"143","author":"Sintini","year":"2020","journal-title":"Brain"},{"issue":"22","key":"10.1016\/bs.acc.2024.11.005_bib186","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216119","article-title":"From recognition to remedy: the significance of biomarkers in neurodegenerative disease pathology","volume":"24","author":"Toader","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/bs.acc.2024.11.005_bib187","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/0360-3016(88)90233-7","article-title":"Myelin basic protein and magnetic resonance imaging for diagnosing radiation myelopathy","volume":"15","author":"Rubin","year":"1988","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/bs.acc.2024.11.005_bib188","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s13311-021-01027-4","article-title":"The use, standardization, and interpretation of brain imaging data in clinical trials of neurodegenerative disorders","volume":"18","author":"Schwarz","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/bs.acc.2024.11.005_bib189","first-page":"313","article-title":"Ethical and social issues in the use of biomarkers in epidemiological research","volume":"142","author":"Schulte","year":"1997","journal-title":"IARC Sci. Publ."},{"issue":"1","key":"10.1016\/bs.acc.2024.11.005_bib190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40258-015-0198-x","article-title":"A systematic review of health economic evaluations of diagnostic biomarkers","volume":"14","author":"Oosterhoff","year":"2016","journal-title":"Appl. Health Econ. Health Policy"},{"issue":"5","key":"10.1016\/bs.acc.2024.11.005_bib191","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.bbapap.2013.12.020","article-title":"Challenges and prospects for biomarker research: a current perspective from the developing world","volume":"1844","author":"Gupta","year":"2014","journal-title":"Biochimica et. Biophysica Acta (BBA) \u2013 Proteins Proteom."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242324001367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242324001367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:52:47Z","timestamp":1740131567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242324001367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443415333"],"references-count":191,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2024.11.005","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}